Induction of apoptosis of human tumor cells by a 4,9-diazapyrenium derivative and its affects on topoisomerase-II action

Chemotherapy

Volumn 51, Issue 4, 2005, Pages 217-222

  Marczi, S ^a   Glavas Obrovac Lj ^a   Karner, I ^a  

^a UNIVERSITY HOSPITAL OSIJEK   (Croatia)

Author keywords

4,9 Diazapyrenium derivatives; Apoptosis; Topoisomerase II

Indexed keywords

5,10 DIPHENYL 4,9 DIMETHYL 4,9 DIAZAPYRENIUM; AGAROSE; BIPHENYL; DNA FRAGMENT; DNA TOPOISOMERASE (ATP HYDROLYSING); FLUORESCEIN; LIPOCORTIN 5; PHOSPHATIDYLSERINE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL DEATH; CELL FREE SYSTEM; CELL STRAIN CACO 2; CELL TYPE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DNA CLEAVAGE; DNA STRAND BREAKAGE; DNA SYNTHESIS; ENZYME ACTIVITY; HUMAN; HUMAN CELL; ISOELECTRIC FOCUSING; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RNA SYNTHESIS; TUMOR CELL LINE;

APOPTOSIS; CACO-2 CELLS; DNA DAMAGE; DNA TOPOISOMERASES, TYPE II; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; PANCREATIC NEOPLASMS; QUINOLINIUM COMPOUNDS; TUMOR CELLS, CULTURED;

EID: 26044445573     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000086923     Document Type: Article

References (26)

1. Palm BS, Piantanida I, Žinić M, Schneider H-J: The interaction of new 4,9-diazapyrenium compounds with double stranded nucleic acids. J Chem Soc Perkin Trans 2000;2:385-392.
2. Piantanida I, Tomišić V, Žinić M: 4,9-Diazapyrenium cations. Synthesis, physico-chemical properties and binding of nucleotides in water. J Chem Soc Perkin Trans 2000;2:375-383.
3. Roknić S, Glavaš-Obrovac Lj, Karner I, Piantanida I, Žinić M, Pavelić K: In vitro cytotoxicity of tree 4,9-diazapyrenium hydrogen-sulfate derivatives on different human tumor cell lines. Chemotherapy 2000;46:143-149.
4. Brana MF, Cacho M, Gradillas A, de Pascual-Teresa B, Ramos A: Intercalators as anticancer drugs. Curr Pharm Des 2001;7:1745-1780.
5. Kellner U, Rudolph P, Parwaresch R: Human DNA-topoisomerases - Diagnostic and therapeutic implications for cancer. Onkologie 2000;23:424-430.
6. Fry DW: Biochemical pharmacology of anthracenediones and anthrapyrazoles. Pharmacol Ther 1991;52:109-125.
7. Subramanian D, Sommer FC, Muller MT: ICE bioassay; in Osheroff N, Bjornsti M-A (eds): DNA Topoisomerase Protocols. Enzymology and Drugs. Totowa, Humana Press, 2001, pp 137-147.
8. Akimitsu N, Kamura K, Toné S, Sakaguchi A, Kikuchi A, Hamamoto H, Sekimizu K: Induction of apoptosis by depletion of DNA topoisomerase II in mammalian cells. Biochem Biophys Res Commun 2003;307:301-307.
9. Kaina B: DNA damage-triggered apoptosis: Critical role of DNA repair, double-strand breaks, cell proliferation and signaling. Biochem Pharmacol 2003;66:1547-1554.
10. Ehlert JE, Kubbutat MHG: Apoptosis and its relevance in cancer therapy. Onkologie 2001;24:433-440.
11. Mickisch G, Fajta S, Keilhauer G, Schlick E, Tschada R, Alken P: Chemosensitivity testing of primary human renal cell carcinoma by a tetrazolium based microculture assay (MTT). Urol Res 1990;18:131-136.
12. Ulukaya E, Colakogullari M, Wood EJ: Interference by anti-cancer chemotherapeutic agents in the MTT-tumor chemosensitivity assay. Chemotherapy 2004;50:43-50.
13. Freshny RI: Culture of Animal Cells: A Manual of Basic Technique, ed 4. New York, Wiley-Liss, 2000, pp 89-104.
14. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning - A Laboratory Manual, ed 2. Cold Spring Harbor, Cold Spring Harbor Laboratory Press, 1989.
15. Burden DA, Froelich-Ammon J, Osheroff N: Topoisomerase II-mediated cleavage of plasmid DNA; in Osheroff N, Bjornsti M-A (eds): DNA Topoisomerase Protocols. Enzymology and Drugs. Totowa, Humana Press, 2001, pp 283-289.
16. Steiner-Biočić, Glavaš-Obrovac Lj, Karner I, Piantanida I, Žinić M, Pavelić K, Pavelić J: 4,9-Diazapyrenium dications induce apoptosis in human tumor cells. Anticancer Res 1996;16:3705-3708.
17. DeVita VT: Principles of cancer management: Chemotherapy; in DeVita VT Jr, Hellman S, Rosenberg SA (eds): Cancer: Principles and practice of oncology. Philadelphia, Lippincott-Raven, 1997, pp 333-347.
18. Chung YH, Youn J, Choi Y, Paik DJ, Cho YJ: Requirement of de novo protein synthesis for aminopterin-induced apoptois in a mouse myeloma cell. Immunol Lett 2001;77:127-131.
19. Hanusch I, Schwieger A, Sers C, Shafer R, Bauer G: Oncogenic transformation increases the sensitivity for apoptosis induction by inhibitors of macromolecular synthesis. Int J Oncol 2000;17:89-95.
20. 2+ chelators and zinc. J Exp Clin Cancer Res 1998;17:277-284.
21. Darzynkiewicz Z, Bedner E, Traganos F, Murakami T: Critical aspects in the analysis of apoptosis and necrosis. Hum Cell 1998;11:3-12.
22. Hurley LH: DNA and its associated processes as targets for cancer therapy. Nature Rev Cancer 2002;2:188-200.
23. Rowe TC, Grabowski D, Ganapathi R: Isolation of covalent enzyme-DNA complexes; in Osheroff N, Bjornsti M-A (eds): DNA Topoisimerase Protocols. Enzymology and Drugs. Totowa, Humana Press, 2001, pp 129-136.
24. Cline S, Osheroff N: Cytosine arabinoside lesions are position-specific topoisomerase II poisons and stimulate DNA cleavage mediated by the human type II enzymes. J Biol Chem 1999;274:29740-29743.
25. Bal C, Baldeyrou, Moz F, Lansiaux A, Colson P, Kraus-Berthier L, Léonce S, Pierré A, Bussard M-F, Rousseau A, Wierzbicki M, Bailly C: Novel antitumor indenoindole derivatives targeting DNA and topoisomerase II. Biochem Pharmacol 2004;68:1911-1922.
26. Kim SG, Sung M, Kang KW, Kim SH, Son MH, Kim WB: DA-125, a novel anthracycline derivative showing high-affinity DNA binding and topoisomerase II inhibitory activities, exerts cytotoxicity via c-Jun N-terminal kinase pathway. Cancer Chemother Pharmacol 2001;47:511-518.